1899 related articles for article (PubMed ID: 28152038)
1. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
2. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
[TBL] [Abstract][Full Text] [Related]
3. The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes.
Monies D; Abouelhoda M; AlSayed M; Alhassnan Z; Alotaibi M; Kayyali H; Al-Owain M; Shah A; Rahbeeni Z; Al-Muhaizea MA; Alzaidan HI; Cupler E; Bohlega S; Faqeih E; Faden M; Alyounes B; Jaroudi D; Goljan E; Elbardisy H; Akilan A; Albar R; Aldhalaan H; Gulab S; Chedrawi A; Al Saud BK; Kurdi W; Makhseed N; Alqasim T; El Khashab HY; Al-Mousa H; Alhashem A; Kanaan I; Algoufi T; Alsaleem K; Basha TA; Al-Murshedi F; Khan S; Al-Kindy A; Alnemer M; Al-Hajjar S; Alyamani S; Aldhekri H; Al-Mehaidib A; Arnaout R; Dabbagh O; Shagrani M; Broering D; Tulbah M; Alqassmi A; Almugbel M; AlQuaiz M; Alsaman A; Al-Thihli K; Sulaiman RA; Al-Dekhail W; Alsaegh A; Bashiri FA; Qari A; Alhomadi S; Alkuraya H; Alsebayel M; Hamad MH; Szonyi L; Abaalkhail F; Al-Mayouf SM; Almojalli H; Alqadi KS; Elsiesy H; Shuaib TM; Seidahmed MZ; Abosoudah I; Akleh H; AlGhonaium A; Alkharfy TM; Al Mutairi F; Eyaid W; Alshanbary A; Sheikh FR; Alsohaibani FI; Alsonbul A; Al Tala S; Balkhy S; Bassiouni R; Alenizi AS; Hussein MH; Hassan S; Khalil M; Tabarki B; Alshahwan S; Oshi A; Sabr Y; Alsaadoun S; Salih MA; Mohamed S; Sultana H; Tamim A; El-Haj M; Alshahrani S; Bubshait DK; Alfadhel M; Faquih T; El-Kalioby M; Subhani S; Shah Z; Moghrabi N; Meyer BF; Alkuraya FS
Hum Genet; 2017 Aug; 136(8):921-939. PubMed ID: 28600779
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
[TBL] [Abstract][Full Text] [Related]
5. Next-generation diagnostics: gene panel, exome, or whole genome?
Sun Y; Ruivenkamp CA; Hoffer MJ; Vrijenhoek T; Kriek M; van Asperen CJ; den Dunnen JT; Santen GW
Hum Mutat; 2015 Jun; 36(6):648-55. PubMed ID: 25772376
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases.
Saudi Mendeliome Group
Genome Biol; 2015 Jun; 16(1):134. PubMed ID: 26112015
[TBL] [Abstract][Full Text] [Related]
7. Clinical validation of targeted next-generation sequencing for inherited disorders.
Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders.
Rabbani B; Mahdieh N; Hosomichi K; Nakaoka H; Inoue I
J Hum Genet; 2012 Oct; 57(10):621-32. PubMed ID: 22832387
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of Targeted Next-Generation Sequencing Panels for Detection of Germline Variants in Inherited Diseases.
Santani A; Murrell J; Funke B; Yu Z; Hegde M; Mao R; Ferreira-Gonzalez A; Voelkerding KV; Weck KE
Arch Pathol Lab Med; 2017 Jun; 141(6):787-797. PubMed ID: 28322587
[TBL] [Abstract][Full Text] [Related]
12. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders.
Dillon OJ; Lunke S; Stark Z; Yeung A; Thorne N; ; Gaff C; White SM; Tan TY
Eur J Hum Genet; 2018 May; 26(5):644-651. PubMed ID: 29453417
[TBL] [Abstract][Full Text] [Related]
13. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges.
de Koning TJ; Jongbloed JD; Sikkema-Raddatz B; Sinke RJ
Expert Rev Mol Diagn; 2015 Jan; 15(1):61-70. PubMed ID: 25367078
[TBL] [Abstract][Full Text] [Related]
14. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B
J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680
[TBL] [Abstract][Full Text] [Related]
15. Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy: Outcomes and Lessons Learned.
Ghaoui R; Cooper ST; Lek M; Jones K; Corbett A; Reddel SW; Needham M; Liang C; Waddell LB; Nicholson G; O'Grady G; Kaur S; Ong R; Davis M; Sue CM; Laing NG; North KN; MacArthur DG; Clarke NF
JAMA Neurol; 2015 Dec; 72(12):1424-32. PubMed ID: 26436962
[TBL] [Abstract][Full Text] [Related]
16. Replicate exome-sequencing in a multiple-generation family: improved interpretation of next-generation sequencing data.
Cherukuri PF; Maduro V; Fuentes-Fajardo KV; Lam K; ; Adams DR; Tifft CJ; Mullikin JC; Gahl WA; Boerkoel CF
BMC Genomics; 2015 Nov; 16():998. PubMed ID: 26602380
[TBL] [Abstract][Full Text] [Related]
17. Contribution of next generation sequencing in pediatric practice in Lebanon. A Study on 213 cases.
Nair P; Sabbagh S; Mansour H; Fawaz A; Hmaimess G; Noun P; Dagher R; Megarbane H; Hana S; Alame S; Lamaa M; Hasbini D; Farah R; Rajab M; Stora S; El-Tourjuman O; Abou Jaoude P; Chalouhi G; Sayad R; Gillart AC; Al-Ali M; Delague V; El-Hayek S; Mégarbané A
Mol Genet Genomic Med; 2018 Nov; 6(6):1041-1052. PubMed ID: 30293248
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility in infants with suspected monogenic conditions through next-generation sequencing.
Hong S; Wang L; Zhao D; Zhang Y; Chen Y; Tan J; Liang L; Zhu T
Mol Genet Genomic Med; 2019 Jun; 7(6):e684. PubMed ID: 30968598
[TBL] [Abstract][Full Text] [Related]
19. [Comparison study of whole exome sequencing and targeted panel sequencing in molecular diagnosis of inherited retinal dystrophies].
Liu XZ; Li YY; Yang LP
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):836-844. PubMed ID: 33047716
[TBL] [Abstract][Full Text] [Related]
20. Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls.
McInerney-Leo AM; Duncan EL
Front Endocrinol (Lausanne); 2020; 11():628946. PubMed ID: 33679611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
